EGFR and cancer: Following statistical analysis of biological pathways being targeted by the drugs in the GDSC2 library, we observed that in comparison to adult cancer cell lines, pediatric cancer cell lines are generally more sensitive to compounds targeting DNA replication, genome integrity and IGFR1 signaling but less sensitive to targeting of ERK, MAPK, EGFR and WNT signaling pathways (Fig. 1b).